DongKoo Bio & Pharma Co., Ltd.
Pharma leader in dermatology, developing treatments, probiotics, and investing in biotech therapies.
006620 | KO
Overview
Corporate Details
- ISIN(s):
- KR7006620009
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 법원로 114, B동 14층, 송파구
- Website:
- https://www.dongkoo.com/eng/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
DongKoo Bio & Pharma Co., Ltd. is a pharmaceutical company founded in 1970 that engages in the research, development, manufacturing, and sale of medical products. The company is a recognized leader in the dermatology prescription market and also offers a portfolio of products including antihistamines, probiotics, and treatments for gum disease. Strategically expanding beyond traditional pharmaceuticals, the company pursues an 'Open Innovation' model to develop differentiated pipelines and invest in future technologies, with a focus on biotechnology and stem cell-based therapies. It operates with world-class research centers and GMP (Good Manufacturing Practice) certified facilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 2.1 MB | ||
| 2025-07-02 00:00 |
M&A Activity
합병등종료보고서(합병)
|
Korean | 16.5 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 125.5 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.0 MB | ||
| 2025-04-30 00:00 |
M&A Activity
주요사항보고서(회사합병결정)
|
Korean | 72.2 KB | ||
| 2025-04-30 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 5.2 KB | ||
| 2025-04-23 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 125.8 KB | ||
| 2025-04-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 125.8 KB | ||
| 2025-03-31 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 6.2 KB | ||
| 2025-03-31 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 32.1 KB | ||
| 2025-03-27 00:00 |
Capital/Financing Update
주요사항보고서(교환사채권발행결정)
|
Korean | 42.7 KB | ||
| 2025-03-27 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 37.7 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 28.5 KB | ||
| 2025-03-26 00:00 |
Remuneration Information
주식매수선택권부여에관한신고
|
Korean | 17.3 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 13.3 KB |
Automate Your Workflow. Get a real-time feed of all DongKoo Bio & Pharma Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DongKoo Bio & Pharma Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DongKoo Bio & Pharma Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
